belantamab mafodotin
gsk
['blenrep', 'dreamm-6', 'mmsm']
dreamm-6 study data on combination therapy of blenrep with lenalidomide (revlimid) shows increased overall response rate with decreased ocular toxicity. further studies may reveal even better partners for blenrep. #mmsm #asco22 
Multiple Myeloma Research Foundation - Accelerating the development of next generation #myeloma treatments to extend patient’s lives, and lead to a cure.